UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): February 3, 2005
MILLENNIUM CHEMICALS INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
| 1-12091 | 22-3436215 | |
| (Commission File Number) | (I.R.S. Employer Identification No.) |
| 1221 McKinney Street, Suite 700, Houston, Texas | 77010 | |
| (Address of principal executive offices) | (Zip Code) |
(713) 652-7200
(Registrant’s telephone number, including area code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 Results of Operations and Financial Condition
On February 3, 2005, Lyondell Chemical Company (“Lyondell”) issued a press release announcing Lyondell’s, Equistar Chemicals, LP’s (“Equistar”) and Millennium Chemicals Inc.’s (“Millennium”) results for the fourth quarter of 2004, which is furnished herewith as Exhibit 99.1 and incorporated by reference into this Item 2.02. As a result of Lyondell’s November 30, 2004 acquisition of Millennium, Equistar and Millennium are wholly owned subsidiaries of Lyondell.
Lyondell will host a conference call on February 3, 2005 at 11:30 a.m. Eastern Time to discuss the results. The call will be broadcast live on Lyondell’s web site at www.lyondell.com/earnings. A replay of the call will be available on the web site at www.lyondell.com/earnings at 2:30 p.m. Eastern Time on February 3, 2005. Reconciliations of non-GAAP financial measures to GAAP financial measures, together with any other applicable disclosures, including the earnings release, will be available at 11:30 a.m. Eastern Time on February 3, 2005 at www.lyondell.com/earnings.
Item 9.01 Financial Statements and Exhibits
| (c) | Exhibits. |
| 99.1 | Press Release (filed as Exhibit 99.1 to Lyondell’s Current Report on Form 8-K dated as of February 3, 2005 and incorporated herein by reference) |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MILLENNIUM CHEMICALS INC. | ||
| By: |
/s/ Kerry A. Galvin | |
| Name: |
Kerry A. Galvin | |
| Title: |
Senior Vice President, General Counsel & Secretary | |
Date: February 3, 2005
INDEX TO EXHIBITS
| Exhibit Number |
Description | |
| 99.1 | Press Release (filed as Exhibit 99.1 to Lyondell’s Current Report on Form 8-K dated as of February 3, 2005 and incorporated herein by reference) |